Intrinsic molecular subtypes of HER2+ breast cancer

Oncotarget. 2017 Sep 4;8(43):73362-73363. doi: 10.18632/oncotarget.20629. eCollection 2017 Sep 26.

Authors

Aleix Prat¹, Tomás Pascual¹, Barbara Adamo¹

Affiliation

¹ Aleix Prat: Department of Medical Oncology, Hospital Clínic de Barcelona, Spain and Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.

No abstract available

Keywords: HER2 blockade; HER2-enriched; HER2-positive; breast cancer; intrinsic subtype.

Publication types

Editorial